Showing 721-730 of 1066 results for "".
- Researchers Find Association Between Dysregulation of Three Genes and MShttps://practicalneurology.com/news/researchers-find-association-between-dysregulation-of-three-genes-and-ms/2470082/New research published in the Annals of Clinical and Translational Neurology has identified dysregulation in three specific genes along with their expressed proteins that may be associated with multiple sclerosis (MS). The three genes were SHMT1, FAM120B, and ICA1L. As part of
- Tofersen Slowed Decline SOD1-Associated Amyotrophic Lateral Sclerosishttps://practicalneurology.com/news/tofersen-slowed-decline-sod1-associated-amyotrophic-lateral-sclerosis/2470036/In the phase 3 VALOR study (NCT02623699), participants with superoxide dismutase 1 (SOD1)-associated amyotrophic lateral sclerosis (ALS) had slowed disease progression when treated with tofersen (
- Sleep Apnea in Pregnancy Associated with Risk of Metabolic Syndrome and Hypertensionhttps://practicalneurology.com/news/sleep-apnea-in-pregnancy-associated-with-risk-of-metabolic-syndrome-and-hypertension/2469823/As published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, sleep disordered breathing during pregnancy has been associated with a 2 to 3-times increased ris
- Cortical Stimulation-Induced Seizures Associated With Improved Epilepsy Surgery Outcomeshttps://practicalneurology.com/news/cortical-stimulation-induced-seizures-associated-with-improved-epilepsy-surgery-outcomes/2468925/Inducing seizures during prehospital stays before epilepsy surgery was associated with improved outcomes as published in JAMA. Evaluating data from 103 patients, researchers sought correlations bet
- American Stroke Association Releases Updated Recommendations for Stroke Care Systemshttps://practicalneurology.com/news/american-stroke-association-releases-updated-recommendations-for-stroke-care-systems/2468908/The American Stroke Association (ASA) has published updated recommendations for stroke care systems (Stroke. 2019;50:00-00). The recommendations comprehensively review evidence evaluating stroke care systems and update previous ASA r
- Exercise Associated With Lower Migraine Frequencyhttps://practicalneurology.com/news/exercise-associated-with-lower-migraine-frequency/2469509/According to a preliminary study that will be presented at the American Academy of Neurology’s 73rd Annual Meeting in April, more than two-thirds of people with migraine do not get enough exercise. Of 4,647 individuals with migraine, 75% with chronic migraine (>15 headache days/month), o
- Significant Treatment Gaps Found in People Diagnosed with Chorea Associated with Huntington Diseasehttps://practicalneurology.com/news/significant-treatment-gaps-found-in-people-diagnosed-with-chorea-associated-with-huntington-disease/2473811/Less than 40% of people diagnosed with chorea associated with Huntington disease (HD) received treatment, according to findings of a large observational study published in Neurology and Therapy. In addition, only ~50% of treated patients received first-line monotherapy with the vesicular
- Novel Treatment Approved for NF1-Associated Symptomatic Plexiform Neurofibromashttps://practicalneurology.com/news/new-treatment-approved-for-nf1-associated-symptomatic-plexiform-neurofibromas/2473785/The Food and Drug Administration (FDA) has approved Gomekli (mirdametinib; SpringWorks Therapeutics, Stamford, CN) for the treatment of neurofibromatosis type 1 (NF1)–associated symptomatic plexiform neurofibromas (PNs) not amenable to complete resection in adults and pediatric patients age
- Investigational Therapy Associated with Reduced Infarct Growth in Individuals with Acute Ischemic Strokehttps://practicalneurology.com/news/investigational-therapy-associated-with-reduced-infarct-growth-in-individuals-with-acute-ischemic-stroke/2473782/Treatment with the investigational therapy RNS60 (Revalesio, Tacoma, WA) was associated with a significant reduction in infarct growth and clinically meaningful improvements for individuals with acute ischemic stroke (AIS) treated within 12 hours of symptom onset. These results were presented at
- Guidelines for Evaluating, Diagnosing, and Disclosing Dementia Published by Alzheimer’s Associationhttps://practicalneurology.com/news/guidelines-for-evaluating-diagnosing-and-disclosing-dementia-published-by-alzheimers-association/2470946/The Diagnostic Evaluation, Testing, Counseling, and Disclosure Clinical Practice Guideline (DETeCD-ADRD CPG) Workgroup, convened and funded by the Alzheimer’s Association, has developed new recommendations for clinicians to use when evaluating patients with possible Alzheimer disease (AD) o